Cybersecurity Platform Engineer - Cyber Tech Services at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, HealthcareIndustries

Requirements

  • Expertise in engineering, deploying, and maintaining security platforms (insider threat detection, secure data exchange, GRC, email security, asset visibility)
  • Ability to work across diverse security technologies and implement integrations for unified security operations
  • Proficiency in developing API-based workflows, data exchange mechanisms, and data pipelines for security telemetry aggregation, correlation, reporting, and analytics
  • Skills in automation scripting with Python, PowerShell, or Bash
  • Experience with Infrastructure-as-Code tools like Terraform or Ansible
  • Knowledge of building CI/CD pipelines for automated testing, validation, and deployment
  • Capability to provide operational support, troubleshooting, incident response, capacity planning, performance tuning, and scalability assessments
  • Experience in platform upgrades, patching, lifecycle management, problem management, and change management processes

Responsibilities

  • Design, deploy, and maintain insider threat monitoring and detection platforms
  • Engineer and optimize secure file transfer and secure data exchange platforms for collaboration with external partners, clinical trial sites, and regulatory agencies
  • Implement and manage email security platforms, including secure email gateways, anti-phishing solutions, and advanced threat protection
  • Deploy and maintain GRC platforms supporting risk assessments, policy management, compliance tracking, and audit workflows
  • Build and operate asset discovery and visibility platforms for IT assets, software, and security posture inventory
  • Implement integrations between Cyber Tech Services platforms and systems like logging, identity management, and ticketing
  • Develop automation scripts, Infrastructure-as-Code solutions, CI/CD pipelines, self-service capabilities, and custom tools
  • Provide engineering support for troubleshooting, security investigations, incident response, capacity planning, performance tuning, and scalability
  • Analyze platform metrics, error rates, utilization trends, and user feedback for optimization
  • Manage platform upgrades, patching, lifecycle activities, problem management, preventive measures, and change management processes

Skills

Insider Threat Detection
Secure Data Exchange
GRC Platforms
Email Security
Secure Email Gateways
Anti-Phishing
Advanced Threat Protection
Asset Discovery
Cybersecurity Engineering
Platform Deployment
Regulatory Compliance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI